Preventability and manageability of adverse drug reactions in COVID-19 with mucormycosis: An observational study.

ABSTRACT:

Background

In the intricate landscape of healthcare amid the COVID-19 pandemic, the emergence of mucormycosis as a severe complication posed a significant challenge to primary healthcare. This study delved into the complexities of adverse drug reactions (ADRs) in COVID-19 patients with mucormycosis undergoing treatment with conventional amphotericin B.

Methods

Ethically approved and meticulously conducted, the study scrutinized 154 ADRs in depth, shedding light on their classification, outcomes, and interventions in COVID patients with mucormycosis. A descriptive analysis was carried out to report the findings of this study.

Results

The findings revealed that a substantial proportion (85.6%) of these ADRs were manageable, emphasizing the need for vigilant monitoring a

SUBMITTER: Dhingra S 

PROVIDER: S-EPMC11504753 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature